BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8943867)

  • 1. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
    Oda A; Miyakawa Y; Druker BJ; Ishida A; Ozaki K; Ohashi H; Wakui M; Handa M; Watanabe K; Okamoto S; Ikeda Y
    Blood; 1996 Dec; 88(11):4304-13. PubMed ID: 8943867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets.
    Miyakawa Y; Oda A; Druker BJ; Ozaki K; Handa M; Ohashi H; Ikeda Y
    Blood; 1997 Apr; 89(8):2789-98. PubMed ID: 9108397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin.
    Oda A; Ozaki K; Druker BJ; Miyakawa Y; Miyazaki H; Handa M; Morita H; Ohashi H; Ikeda Y
    Blood; 1996 Aug; 88(4):1330-8. PubMed ID: 8695851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
    Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation.
    ten Bosch GJ; Kessler JH; Blom J; Joosten AM; Gambacorti-Passerini C; Melief CJ; Leeksma OC
    Br J Haematol; 1998 Dec; 103(4):1109-15. PubMed ID: 9886328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets.
    Ozaki K; Oda A; Wakao H; Rhodes J; Druker BJ; Ishida A; Wakui M; Okamoto S; Morita K; Handa M; Komatsu N; Ohashi H; Miyajima A; Ikeda Y
    Blood; 1998 Dec; 92(12):4652-62. PubMed ID: 9845531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
    Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
    Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation via the collagen receptor GPVI is not altered in platelets from chronic myeloid leukaemia patients despite the presence of the constitutively phosphorylated adapter protein CrkL.
    Best D; Pasquet S; Littlewood TJ; Brunskill SJ; Pallister CJ; Watson SP
    Br J Haematol; 2001 Mar; 112(3):609-15. PubMed ID: 11260061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia.
    Shibata K; Nishimura J; Yufu Y; Nawata H
    Int J Hematol; 1992 Apr; 55(2):189-96. PubMed ID: 1387329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
    Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
    Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
    Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation.
    Kubota Y; Tanaka T; Ohnishi H; Kitanaka A; Okutani Y; Taminato T; Ishida T; Kamano H
    Leukemia; 2004 Jun; 18(6):1127-37. PubMed ID: 15085152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
    J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets.
    Oda A; Ochs HD; Druker BJ; Ozaki K; Watanabe C; Handa M; Miyakawa Y; Ikeda Y
    Blood; 1998 Sep; 92(6):1852-8. PubMed ID: 9731041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
    Salgia R; Sattler M; Pisick E; Li JL; Griffin JD
    Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.